MRK logo

Merck & Co (MRK)

Profile

Full Name

Merck & Co., Inc.

Ticker Symbol

MRK

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

January 13, 1978

Indexes

S&P 500,Dow Jones

Website

http://www.merck.com

Employees

73000

Key Details

Price

$83.18(-0.10%)

Market cap

$209.31B(Mega cap)

Last Dividend

$0.81

TTM Dividend yield

3.80%

Annual revenue

$64.17B(+6.74% YoY)

Annual EPS

$6.74(+4714.29% YoY)

PE ratio

12.11

Next earnings date

Jul 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$83.18
MRK price is $83.18

30-Day Relative Volume

0.64
MRK 30-day relative volume is 0.64

Price Performance

Price Most recent change

-0.1%
MRK price was down -0.1% on May 2, 2025

Price YTD change

-16.39%
MRK price is down -16.39% since January 1st

Price 1-year change

-35.15%
MRK price is down -35.15% year-on-year

Price 3-year change

-5.1%
MRK price is down -5.1% over the past 3 years

Price Range

Price All-time high

$134.63
MRK price is currently -38.22% below its historical high of $134.63

Price 3-year low

$75.93
MRK price is currently +9.55% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$209.31B
MRK market capitalization is $209.31 billion

Market cap 3-year change

-5.57%
MRK market capitalization is down -5.57% over the past 3 years

Market cap All-time high

$337.37B
MRK market capitalization is currently -37.96% below its historical high of $337.37 billion

Market cap sector rank

99.35%
MRK market capitalization is higher than 99.35% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.65%
MRK shares outstanding is down -0.65% year-on-year

Shares Outstanding 3-Year Change

-0.49%
MRK shares outstanding is down -0.49% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.26
MRK beta is 0.26

200-day SMA

$101.38
MRK price is currently -17.95% below its 200-day simple moving average

50-day SMA

$87.22
MRK price is currently -4.63% below its 50-day simple moving average

RSI

49.53
MRK 14-day relative strength index is 49.53

Volume

0.64
MRK 30-day relative volume is 0.64

ATR

$2.88
MRK average true range is $2.88

10-day Historical Volatility

24.94%
MRK 10-day historical volatility is 24.94%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.81
MRK last dividend was $0.81 per share, with an ex-dividend date of March 17, 2025

Next Dividend

-
MRK next dividend has not yet been announced

Dividend per share

Dividend per share

$3.12
MRK annual dividend per share is $3.12

Dividend per share Sector Rank

85.06%
MRK annual dividend per share is higher than 85.06% of companies in Healthcare sector

Dividend per share 1-Year Change

+5.41%
MRK annual dividend per share is up +5.41% year-on-year

Dividend per share 3-Year Change

+18.18%
MRK annual dividend per share is up +18.18% over the past 3 years

Dividend yield

Dividend yield

3.75%
MRK annual dividend yield is 3.75%

Dividend yield Sector Rank

75.58%
MRK annual dividend yield is higher than 75.58% of companies in Healthcare sector

Other

Payout ratio

45.80%
MRK annual payout ratio is 45.80%

Dividends paid

$7.84B
MRK annual dividends paid is $7.84 billion

Free cash flow

$18.10B
MRK annual free cash flow is $18.10 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$64.17B
MRK annual revenue is $64.17 billion

Revenue Analysts estimate

$65.08B
MRK annual revenue is currently -1.40% lower than the consensus analysts' forecast

Revenue 1-year change

+6.74%
MRK annual revenue is up +6.74% year-on-year

Revenue Sector rank

98.65%
MRK annual revenue is higher than 98.65% of companies in Healthcare sector

EPS

EPS

$6.74
MRK annual earnings per share is $6.74

EPS Analysts estimate

$8.92
MRK annual earnings per share is currently -24.43% lower than the consensus analysts' forecast

EPS 1-year change

+4714.29%
MRK annual earnings per share is up +4714.29% year-on-year

EPS Sector rank

96.94%
MRK annual earnings per share is higher than 96.94% of companies in Healthcare sector

Profit

Gross profit

$48.98B
MRK annual gross profit is $48.98 billion

Gross margin

76.32%
MRK annual gross profit margin is 76.32%

Operating profit

$20.22B
MRK annual operating income is $20.22 billion

Operating margin

31.51%
MRK annual operating profit margin is 31.51%

Net income

$17.12B
MRK annual net profit is $17.12 billion

Net margin

26.68%
MRK annual net profit margin is 26.68%

Expenses

Total expenses

$43.95B
MRK annual total expenses is $43.95 billion

Operating expenses

$28.75B
MRK annual total operating expenses is $28.75 billion

Cost of goods sold

$15.19B
MRK annual cost of goods sold is $15.19 billion

Selling, general & administrative expenses

$10.82B
MRK annual SGA is $10.82 billion

Depreciation and amortization

$4.50B
MRK annual depreciation & amortization is $4.50 billion

Interest expense

$1.27B
MRK annual interest expense is $1.27 billion

Income tax

$2.80B
MRK annual income tax is $2.80 billion

EBIT & EBITDA

EBIT

$20.22B
MRK annual earnings before interest & taxes is $20.22 billion

EBITDA

$20.22B
MRK annual EBITDA is $20.22 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$117.11B
MRK annual total assets is $117.11 billion

Non current assets

$78.32B
MRK annual long term assets is $78.32 billion

Current assets

$38.78B
MRK annual total current assets is $38.78 billion

Cash and cash equivalents

$13.24B
MRK annual cash & cash equivalents is $13.24 billion

Accounts receivable

$10.28B
MRK annual accounts receivable is $10.28 billion

Inventory

$6.11B
MRK annual inventory is $6.11 billion

Liabilities

Total liabilities

$70.73B
MRK annual total liabilities is $70.73 billion

Long term liabilities

$42.31B
MRK annual total long term liabilities is $42.31 billion

Current liabilities

$28.42B
MRK annual total current liabilities is $28.42 billion

Accounts payable

$4.08B
MRK annual accounts payable is $4.08 billion

Debt

Total debt

$37.11B
MRK annual total debt is $37.11 billion

Total debt 1-year change

+5.87%
MRK annual total debt is up +5.87% year-on-year

Long term debt

$34.46B
MRK annual long term debt is $34.46 billion

Short term debt

$2.65B
MRK annual short term debt is $2.65 billion

Equity & Capital

Shareholders equity

$46.31B
MRK annual stockholders equity is $46.31 billion

Book value

$46.31B
MRK annual book value is $46.31 billion

Retained earnings

$63.07B
MRK annual retained earnings is $63.07 billion

Working capital

$10.36B
MRK annual working capital is $10.36 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$21.47B
MRK annual cash flow from operations is $21.47 billion

Cash from operations 1-year change

+65.06%
MRK annual cash flow from operations is up +65.06% year-on-year

Cash from investing

-$7.73B
MRK annual cash flow from investing activities is -$7.73 billion

Cash from investing 1-year change

+45.08%
MRK annual cash flow from investing activities is up +45.08% year-on-year

Cash from financing

-$7.03B
MRK annual cash flow from financing activities is -$7.03 billion

Cash from financing 1-year change

-46.2%
MRK annual cash flow from financing activities is down -46.2% year-on-year

CAPEX

CAPEX

$3.37B
MRK annual capital expenditures is $3.37 billion

CAPEX 1-year change

-12.71%
MRK annual capital expenditures is down -12.71% year-on-year

Free Cash Flow

Free cash flow

$18.10B
MRK annual free cash flow is $18.10 billion

Free cash flow 1-year change

+97.92%
MRK annual free cash flow is up +97.92% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

76.32%
MRK annual gross profit margin is 76.32%

Operating margin

31.51%
MRK annual operating profit margin is 31.51%

Net margin

26.68%
MRK annual net profit margin is 26.68%

ROA & ROE

ROA

15.30%
MRK annual return on assets is 15.30%

ROE

40.75%
MRK annual return on equity is 40.75%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

12.11
MRK price to earnings ratio is 12.11

PE ratio Sector rank

18.05%
MRK price to earnings ratio is higher than 18.05% of companies in Healthcare sector

PB Ratio

PB ratio

-
MRK price to book ratio value is unknown

PB ratio Sector rank

-
MRK price to book ratio is unknown

PS Ratio

PS ratio

3.27
MRK price to sales ratio is 3.27

PS ratio Sector rank

51.68%
MRK price to sales ratio is higher than 51.68% of companies in Healthcare sector

Enterprise value

Enterprise value

-
MRK enterprise value value is unknown

Enterprise value Sector rank

-
MRK enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
MRK EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
MRK EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.36
MRK annual current ratio is 1.36

Quick ratio

1.15
MRK annual quick ratio is 1.15

Leverage

Debt to equity

0.80
MRK annual debt to equity ratio is 0.80

Interest coverage ratio

15.91
MRK annual interest coverage ratio is 15.91

Risk & Stability

Piotroski F-Score

-
MRK piotroski f-score value is unknown

Altman Z-Score

3.75
MRK altman z-score is 3.75

Analyst ratings

Recent major analysts updates

Apr 22, 25 Cantor Fitzgerald
Neutral
Apr 17, 25 Guggenheim
Buy
Feb 18, 25 Deutsche Bank
Hold
Feb 12, 25 Guggenheim
Buy
Feb 5, 25 Morgan Stanley
Equal-Weight
Feb 5, 25 Citigroup
Buy
Feb 5, 25 BMO Capital
Market Perform
Feb 5, 25 B of A Securities
Buy
Jan 28, 25 Citigroup
Buy
Jan 21, 25 Morgan Stanley
Equal-Weight

Institutional Ownership

Similar stocks

AZN logo
AstraZeneca (AZN)
NVS logo
Novartis AG (NVS)
ISRG logo
Intuitive Surgical (ISRG)
ABT logo
Abbott Laboratories (ABT)
TMO logo
Thermo Fisher Scientific (TMO)
BSX logo
Boston Scientific (BSX)
AMGN logo
Amgen (AMGN)
SYK logo
Stryker (SYK)
DHR logo
Danaher (DHR)
  • What is the ticker symbol for Merck & Co?
  • Does Merck & Co pay dividends?
  • What sector is Merck & Co in?
  • What industry is Merck & Co in?
  • What country is Merck & Co based in?
  • When did Merck & Co go public?
  • Is Merck & Co in the S&P 500?
  • Is Merck & Co in the NASDAQ 100?
  • Is Merck & Co in the Dow Jones?
  • When was Merck & Co's last earnings report?
  • When does Merck & Co report earnings?
  • Should I buy Merck & Co stock now?

What is the ticker symbol for Merck & Co?

The ticker symbol for Merck & Co is NYSE:MRK

Does Merck & Co pay dividends?

Yes, Merck & Co pays dividends. The last payment was $0.81, with an ex-dividend date on March 17, 2025

What sector is Merck & Co in?

Merck & Co is in the Healthcare sector

What industry is Merck & Co in?

Merck & Co is in the Drug Manufacturers - General industry

What country is Merck & Co based in?

Merck & Co is headquartered in United States

When did Merck & Co go public?

Merck & Co's initial public offering (IPO) was on January 13, 1978

Is Merck & Co in the S&P 500?

Yes, Merck & Co is included in the S&P 500 index

Is Merck & Co in the NASDAQ 100?

No, Merck & Co is not included in the NASDAQ 100 index

Is Merck & Co in the Dow Jones?

Yes, Merck & Co is included in the Dow Jones index

When was Merck & Co's last earnings report?

Merck & Co's most recent earnings report was on Apr 24, 2025

When does Merck & Co report earnings?

The next expected earnings date for Merck & Co is Jul 29, 2025

Should I buy Merck & Co stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page